Docket Entries Since Last Update
NOTE: This court's RSS feed does not list MOTION entries, so Bloomberg Law cannot detect them and thus they will not be listed here. However, motions will be included if you update the docket.
Court Dockets
U.S. Court of Appeals for the Federal Circuit
Docket for Case #: 21-1071
Docket for Case #: 21-1071
Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V.
DOCKET INFORMATION
Minimize
| ||||||||
| ||||||||
| ||||||||
|
| ||||||||
Expand All
| Intervenor |
ANDREI IANCU, Under Secretary of Commerce for Intellectual Property and Director of
the United States Patent and Trademark Office
Intervenor
| |
| Entry | Filed | Description | |
|---|---|---|---|
| BL-1 | Oct 20, 2020 | View | Appeal docketed. Received: 10/20/2020. [730178] <br>Entry of Appearance is due on 11/03/2020. Certificate of Interest is due on 11/03/2020. Docketing Statement is due on 11/03/2020. Certified List is due on 11/30/2020. [EKD] |
| BL-2 | Nov 3, 2020 | Request | Entry of appearance for Pratik A. Shah; Z.W. Julius Chen; Ruben H. Munoz; Barbara L. Mullin; Andrew D. Cohen as counsel for Appellee Janssen Pharmaceutica, N.V.. Service: 11/03/2020 by email. [733432] [21-1071] [Pratik Shah] |
| BL-3 | Nov 3, 2020 | Request | Certificate of Interest for Appellee Janssen Pharmaceutica, N.V.. Service: 11/03/2020 by email. [733433] [21-1071] [Pratik Shah] |
| BL-4 | Nov 3, 2020 | Request | Docketing Statement for the Appellee Janssen Pharmaceutica, N.V.. Service: 11/03/2020 by email. [733434] [21-1071] [Pratik Shah] |
| BL-5 | Nov 3, 2020 | View | Docketing Statement for the Appellant Mylan Laboratories Ltd.. Service: 11/03/2020 by email. [733439] [21-1071] [Deepro Mukerjee] |
| BL-6 | Nov 3, 2020 | Request | Entry of appearance for Deepro R. Mukerjee; Lance A. Soderstrom; Jitendra Malik; Eric Werlinger as counsel for Appellant Mylan Laboratories Ltd.. Service: 11/03/2020 by email. [733442] [21-1071] [Deepro Mukerjee] |
| BL-7 | Nov 3, 2020 | Request | Certificate of Interest for Appellant Mylan Laboratories Ltd.. Service: 11/03/2020 by email. [733443] [21-1071] [Deepro Mukerjee] |
| BL-8 | Nov 5, 2020 | View | MOTION of Appellee Janssen Pharmaceutica, N.V. to terminate appeal through dismissal. Cases to be terminated: 21-1071. (Briefing suspended pursuant to FCR 31 pending resolution of the motion).. Service: 11/05/2020 by email. [734058] [21-1071] [Pratik Shah] |
| BL-9 | Nov 9, 2020 | View | MOTION of Appellant Mylan Laboratories Ltd. to extend time. Service: 11/09/2020 by email. [734587] [21-1071] [Eric Werlinger] |
| BL-10 | Nov 13, 2020 | View | ORDER granting motion to extend time to file . Mylan's response to the motion to dismiss is due no later than December 7, 2020. Service as of this date by the Clerk of Court. [735452] [NL] |
| BL-11 | Nov 30, 2020 | Request | Notice from the United States Patent and Trademark Office of non-filing of the certified list. Service: 11/30/2020 by email. [738852] [EKD] |
| BL-12 | Dec 3, 2020 | Request | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 12/03/2020 by email. [739935] [21-1071] [Michael Forman] |
| BL-13 | Dec 3, 2020 | Request | Entry of appearance for Michael S. Forman; Mary L. Kelly; Molly R. Silfen; Thomas W. Krause; Farheena Y. Rasheed as counsel for Intervenor, Director - U.S. Patent and Trademark Office. Service: 12/03/2020 by email. [739936] [21-1071] [Michael Forman] |
| BL-14 | Dec 7, 2020 | View | RESPONSE from USPTO Director to the motion . Service: 12/07/2020 by email. [740776] [21-1071] [Michael Forman] |
| BL-15 | Dec 7, 2020 | Request | Entry of appearance for Johnjerica Hodge as counsel for Appellant Mylan Laboratories Ltd.. Service: 12/07/2020 by email. [740828] [21-1071] [Johnjerica Hodge] |
| BL-16 | Dec 7, 2020 | View | RESPONSE of Appellant Mylan Laboratories Ltd. to the motion . Service: 12/07/2020 by email. [740923] [21-1071] [Eric Werlinger] |
| BL-17 | Dec 7, 2020 | View | MOTION of Appellee Janssen Pharmaceutica, N.V. to extend time. Service: 12/07/2020 by email. [740926] [21-1071] [Pratik Shah] |
| BL-18 | Dec 8, 2020 | View | ORDER granting motion to extend time filed by Appellee Janssen Pharmaceutica, N.V. Janssen's reply in support of its motion to dismiss is due no later than December 21, 2020. Service as of this date by the Clerk of Court. [741102] [LMS] |
| BL-19 | Dec 21, 2020 | View | REPLY of Appellee Janssen Pharmaceutica, N.V. to response . Service: 12/21/2020 by email. [744389] [21-1071] [Pratik Shah] |
| BL-20 | Jan 14, 2021 | View | ORDER filed granting the Director's motion to intervene. The revised official caption is reflected above. The Director is directed to file a docketing statement no later than 14 days from the date of filing of this order. Telephonic oral argument on the motion to dismiss is scheduled for Friday, February 12, 2021 at 10:00 a.m. Janssen, Mylan, and the Director will each be allotted fifteen minutes for argument. (Per Curiam). Service as of this date by the Clerk of Court. [749374] [LMS] |
| BL-21 | Jan 14, 2021 | Request | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2102N. Case scheduled February 12, 2021. Response to Notice of Oral Argument due: 01/21/2021. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found <a href="http://www.cafc.uscourts.gov/sites/default/files/rules-of-practice/forms/form33.pdf">here</a>. The Oral Argument Guide can be found <a href="http://www.cafc.uscourts.gov/sites/default/files/arguments/OralArgumentGuide.pdf">here</a>. Service as of this date by the Clerk of Court. [749605] [MJL] |
| BL-22 | Jan 15, 2021 | Request | Clerk's letter to Appellant Mylan Laboratories Ltd., Appellee Janssen Pharmaceutica, N.V. and Intervenor Andrei Iancu regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [749810] [JAB] |
| BL-23 | Jan 21, 2021 | View | Response to notice of oral argument from Intervenor Andrei Iancu. Service: 01/21/2021 by email. [750401] [21-1071] [Michael Forman] |
| BL-24 | Jan 21, 2021 | View | Response to notice of oral argument from Appellee Janssen Pharmaceutica, N.V.. Service: 01/21/2021 by email. [750438] [21-1071] [Pratik Shah] |
| BL-25 | Jan 21, 2021 | View | Response to notice of oral argument from Appellant Mylan Laboratories Ltd.. Service: 01/21/2021 by email. [750657] [21-1071] [Deepro Mukerjee] |
| BL-26 | Jan 28, 2021 | Request | Docketing Statement for the Intervenor Andrei Iancu. Service: 01/28/2021 by email. [752305] [21-1071] [Michael Forman] |
| BL-27 | Jan 29, 2021 | View | ORDER filed. The parties and the United States should come to argument prepared to address the questions raised in this order (see attached). By: Per Curiam. Service as of this date by the Clerk of Court. [752881] [MJL] |
| BL-28 | Feb 2, 2021 | View | Entry of appearance for Melissa N. Patterson; Weili J. Shaw as counsel for Intervenor Andrei Iancu. Service: 02/02/2021 by email. [753373] [21-1071] [Melissa Patterson] |
| BL-29 | Feb 2, 2021 | View | Amended Response to notice of oral argument from Intervenor Andrei Iancu. Service: 02/02/2021 by email. [753374] [21-1071] [Melissa Patterson] |
| BL-30 | Feb 11, 2021 | Request | Official caption revised to reflect Andrew Hirshfeld as Performing the Functions and Duties of the Under Secretary of Commerce for Intellectual Property and Director of the USPTO. (see attached). Service as of this date by the Clerk of Court. [755563] [MJL] |
| BL-31 | Feb 12, 2021 | Request | Submitted after ORAL ARGUMENT on Appellee's Motion to Dismiss to Panel: Newman, Circuit Judge; Moore, Circuit Judge and Stoll, Circuit Judge.<br>Arguing counsel: Deepro Mukerjee for Mylan Laboratories Ltd., Mr. Pratik A. Shah for Janssen Pharmaceutica, N.V. and Melissa N. Patterson for Andrew Hirshfeld.<br>Oral Argument Audio available <a href="http://oralarguments.cafc.uscourts.gov/default.aspx?fl=21-1071_02122021.mp3">here</a>. [755787] [JCP] |
| BL-32 | Mar 12, 2021 | View | PRECEDENTIAL ORDER filed. Janssen's motion to dismiss is granted. Mylan's petition for a writ of mandamus is denied. Costs are awarded to Janssen. By: Motions Panel. Service as of this date by the Clerk of Court. [761791] [MJL] |
| BL-33 | May 3, 2021 | Request | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [772445] [MVH] |
| BL-34 | Aug 13, 2021 | Request | Petition for writ of certiorari filed on 08/09/2021 in the U.S. Supreme Court. No.: 21-202, Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V. [793607] [MJL] |
| BL-35 | Jan 18, 2022 | Request | The petition for writ of certiorari, No. 21-202, filed on 08/09/2021, was Denied on 01/18/2022. [825660] [MVH] |